MENU
+Compare
EVAX
Stock ticker: NASDAQ
AS OF
Sep 15 closing price
Price
$2.92
Change
-$0.02 (-0.68%)
Capitalization
18.44M

EVAX Evaxion A/S Forecast, Technical & Fundamental Analysis

Evaxion AS is a techBio company based on its AI platform, AI-Immunology... Show more

EVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for EVAX with price predictions
Sep 15, 2025

Momentum Indicator for EVAX turns positive, indicating new upward trend

EVAX saw its Momentum Indicator move above the 0 level on September 15, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 80 similar instances where the indicator turned positive. In of the 80 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

EVAX moved above its 50-day moving average on September 05, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EVAX advanced for three days, in of 203 cases, the price rose further within the following month. The odds of a continued upward trend are .

EVAX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The Moving Average Convergence Divergence Histogram (MACD) for EVAX turned negative on August 28, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 40 similar instances when the indicator turned negative. In of the 40 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EVAX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.962) is normal, around the industry mean (20.594). P/E Ratio (0.000) is within average values for comparable stocks, (53.282). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.156). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (5.807) is also within normal values, averaging (342.112).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. EVAX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EVAX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
EVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Dr. Neergaards Vej 5f
Phone
+45 31319753
Employees
49
Web
https://www.evaxion-biotech.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ADAP0.070.01
+18.93%
Adaptimmune Therapeutics plc
MRBK15.520.36
+2.37%
Meridian Corp
ABEV2.330.03
+1.30%
Ambev SA
PSFE13.95-0.10
-0.71%
Paysafe Limited
AVAL3.34-0.13
-3.75%
Grupo Aval Acciones Y Valores SA

EVAX and Stocks

Correlation & Price change

A.I.dvisor tells us that EVAX and LPTX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EVAX and LPTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EVAX
1D Price
Change %
EVAX100%
-0.85%
LPTX - EVAX
32%
Poorly correlated
+3.58%
KURA - EVAX
31%
Poorly correlated
+0.24%
KYTX - EVAX
28%
Poorly correlated
-0.26%
HYPD - EVAX
28%
Poorly correlated
-22.83%
DWTX - EVAX
26%
Poorly correlated
-0.40%
More